Colgate-Palmolive Co. (NYSE:CL) shares, rose in value on Friday, March 15, with the stock price up by 0.29% to the previous day’s close as strong demand from buyers drove the stock to $88.61.
Actively observing the price movement in the recent trading, the stock is buoying the session at $88.35. The value of beta (5-year monthly) is 0.41 whereas the PE ratio is 31.91 over 12-month period. Referring to stock’s 52-week performance, its high was $89.36, and the low was $67.62. On the whole, CL has fluctuated by 5.85% over the past month.
With the market capitalization of Colgate-Palmolive Co. currently standing at about $72.94 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 26, 2024. The company’s Forward Dividend Ratio is 1.92, with its dividend yield at 2.17%. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.81, which is expected to increase to $0.88 for fiscal year $3.49 and then to about $3.8 by fiscal year 2025. Data indicates that the EPS growth is expected to be 8.00% in 2025, while the next year’s EPS growth is forecast to be 8.90%.
Analysts have estimated the company’s revenue for the quarter at $4.95 billion, with a low estimate of $4.9 billion and a high estimate of $5.05 billion. According to the average forecast, sales growth in current quarter could jump up 3.80%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $20.18 billion, representing an increase of 3.70% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CL’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 3.81, with the price of CL currently trading nearly 2.26% and 5.53% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 70.10, while the 7-day volatility ratio is showing 1.17% which for the 30-day chart, stands at 1.21%. Furthermore, Colgate-Palmolive Co. (CL)’s beta value is 0.41, and its average true range (ATR) is 1.09.
A comparison of Colgate-Palmolive Co. (CL) with its peers suggests the former has fared considerably weaker in the market. CL showed an intraday change of 0.29% in today’s session so far, and over the past year, it grew by 21.49%%.
Data on historical trading for Colgate-Palmolive Co. (NYSE:CL) indicates that the trading volumes over the past 10 days have averaged 3.55 million and over the past 3 months, they’ve averaged 4.80 million. According to company’s latest data on outstanding shares, there are 823.15 million shares outstanding.
Nearly 0.13% of Colgate-Palmolive Co.’s shares belong to company insiders and institutional investors own 85.31% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.91 million shares as on Feb 29, 2024, resulting in a short ratio of 2.32. According to the data, the short interest in Colgate-Palmolive Co. (CL) stood at 1.45% of shares outstanding as of Feb 29, 2024; the number of short shares registered in Jan 31, 2024 reached 10.09 million. The stock has risen by 11.16% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CL stock heading into the next quarter.
